Integral Solutions develops next-generation psychobiotics to improve brain health and cognitive function. By leveraging precision medicine and gene-editing technology, they create targeted, non-addictive therapeutics that modulate the gut microbiome to enhance healthspan and promote holistic well-being.
Funding
Funding not disclosed
Founders
Product
Problem
Neurological conditions represent the leading cause of global morbidity and disability, impacting over one-third of the population. Current therapeutic approaches often fall short in addressing the complex interplay between the gut microbiome and brain health, leading to suboptimal outcomes for cognitive well-being and overall healthspan.
Solution
Integral Solutions is developing next-generation psychobiotics to address brain health issues and optimize cognitive function. Our approach leverages precision medicine and advanced gene-editing technology to create evidence-based, non-addictive solutions that enhance healthspan and promote holistic well-being. By focusing on the gut-brain axis, we aim to deliver targeted therapeutics that improve mental and physical health through microbiome modulation. Our commitment is to advance microbiome-based interventions for a balanced and healthier life.
Target Audience
Our primary customers are individuals seeking to improve cognitive function and overall brain health, as well as healthcare providers and researchers interested in microbiome-based therapeutics.
Features
- Next-generation psychobiotics targeting brain health and cognitive enhancement.
- Precision medicine approach tailored to individual microbiome profiles.
- Utilization of CRISPR gene-editing technology to optimize probiotic efficacy.
- Development of non-addictive, evidence-based therapeutic solutions.
- Focus on enhancing healthspan and promoting holistic well-being.
- Addressing the gut-brain axis for improved mental and physical health outcomes.